Functional determination of factor XII in plasma

Clinical and Applied Thrombosis/Hemostasis

Volumn 2, Issue 2, 1996, Pages 123-129

  Schousboe, Inger ^a   Røjkær, Rasmus ^a   Lintner, Rita ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Determination; Factor XII; Hageman factor; Plasma

Indexed keywords

EID: 0345338192     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969600200207     Document Type: Article

References (24)

1. Lämmle B, Wuillemin WA, Huber I, et al. Thromboembolism and bleeding tendency in congenital factor XII deficiency - a study on 74 subjects from 14 Swiss families. Thromb Haemost 1991;65:117.
2. Halbmayer W-M, Mannhalter C, Feichtinger C, Rubi K, Fischer M. The prevalence of factor-XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism. Thromb Haemost 1992;68:285.
3. Levi M, Hack CE, de Boer JP, Brandjes DP, Buller HR, ten Cate HW. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo. J Clin Invest 1991;88:1155.
4. Gandolfo GM, Afeltra A, Amoroso A, Biancolella F, Ferri GM. Circulating anticoagulation against factor XII and platelet antibodies in systemic lupus eruthematosus. Acta Hematol 1977;57:135.
5. Jaeger U, Kapiotis S, Pabinger I, Puchhammer E, Kyrle PA, Lechner K. Transient lupus anticoagulant associated with hypothrombinemia and factor XII deficiency following adenovirus infection. Ann Hematol 1993;67:95.
6. Halbmayer W-M, Haushofer A, Schön R, et al. The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence of FXII deficiency among 300 healthy blood donors. Thromb Haemost 1994;71:68.
7. Schved JF, Gris JC, Neveu S, Mares P, Sarlat C. Variations of factor XII level during pregnancy in woman with Hageman factor deficiency. Thromb Haemost 1988;60:526.
8. Lao TT, Lewinsky RM, Ohlsson A, Cohen H. Factor XII deficiency and pregnancy. Obstet Gynecol 1991;78:491.
9. Kluft C, Svendsen L, Los P. Direct assay of factor XIIa in plasma with synthetic chromogenic substrates. Adv Exp Med Biol 1983;156:201.
10. Egberg N, Övermark-Berggren I. Assay for Hageman factor (factor XII) in human plasma by means of chromogenic substrate for plasma kallikrein. Thromb Res 1983;31:875.
11. Tankersley D, Alving BM, Finlayson JS. Activation of factor XII by dextran sulfate: the basis for an assay of factor XII. Blood 1983;62:448.
12. Walshe KJ, Mackie IJ, Gallimore M, Machin SJ. A microtitre chromogenic substrate assay for factor XII. Thromb Res 1987;47:365.
13. Stürzebecher J, Svendsen L, Eichenberger R, Markwardt F. A new assay for the determination of factor XII in plasma using a chromogenic substrate and a selective inhibitor of plasma kallikrein. Thromb Res 1989;55:709.
14. Tans G, Janssen-Claessen T, Rosing J, Griffin JH. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa. Eur J Biochem 1987;164: 637.
15. Schousboe I. Contact activation in human plasma is triggered by zinc ion modulation of factor XII (Hageman Factor). Blood Coag Fibrinol 1993;4:671.
16. Broe MK, Ingild A. Amplification of immunoprecipitates in agarose gels by horseradish peroxidase-labelled antibody. Scand J Immunol 1983;17:255.
17. Colman RW. Surface-mediated defense reactions: the plasma contact activation system. J Clin Invest 1984;73: 1249.
18. Wuillemin A, Furlan M, Lämmle B. A quantitative dot immunobinding assay for coagulation factor XII in plasma. J Immunol Methods 1990;130:133.
19. Wuillemin WA, Huber I, Furlan M, Lämmle B. Functional characterization of an abnormal factor XII molecule (F XII-Bern). Blood 1991;78:997.
20. Wuillemin A, Furlan M, Stricker H, Lämmle B. Functional characterization of a variant factor XII (F XII Locarno) in a cross reacting material positive F XII deficient plasma. Thromb Haemost 1992;67:219.
21. Furlan M, Hovinga JK, Lämmle B. New molecular defect of Factor XII. Presented at the 40th Annual Meeting of the Scientific and Standardization Committee, Leuven, Belgium, 1994.
22. Pixley RA, Cassello A, De La Cadena RA, Kaufman N, Colman RW. Effect of heparin on the activation of Factor XII and the contact system in plasma. Thromb Haemost 1991;66:540.
23. Schousboe I, Rasmussen MS, Lintner R. Dextran sulphate inhibits phospholipid and sulfatide mediated autoactivation of factor XII. Blood Coag Fibrinol 1994;5:503.
24. 2-glycoprotein I. Thromb Haemost 1995;73:798.